BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 12185503)

  • 21. Investigation of monoclonal gammopathy of undetermined significance: a single-centre study.
    Simon Z; Sipka S; Gergely L; Csípö I; Illés A
    Clin Lab Haematol; 2006 Jun; 28(3):164-9. PubMed ID: 16706932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Monoclonal gammopathies of undetermined significance].
    Krizalkovicová V; Maisnar V; Pour L; Radocha J; Hájek R
    Klin Onkol; 2008; 21(4):160-4. PubMed ID: 19102222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between monoclonal gammopathy of undetermined significance and venous thromboembolic disease.
    Cohen AL; Sarid R
    Thromb Res; 2010 Mar; 125(3):216-9. PubMed ID: 19193398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidental monoclonal protein: current approach to management of monoclonal gammopathy of undetermined significance (MGUS).
    Madan S; Greipp PR
    Blood Rev; 2009 Nov; 23(6):257-65. PubMed ID: 19699016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.
    Gregersen H; Mellemkjaer L; Ibsen JS; Dahlerup JF; Thomassen L; Sørensen HT
    Haematologica; 2001 Nov; 86(11):1172-9. PubMed ID: 11694403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal gammopathy of undetermined significance.
    Kyle RA; Rajkumar SV
    Br J Haematol; 2006 Sep; 134(6):573-89. PubMed ID: 16938117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort study.
    Soler JA; Güell M; Bricullé M; Gavarró A; Roig I; Sanchez J; Gisbert JP; García P; Villoria A; Calvet X
    Ann Hematol; 2009 Aug; 88(8):769-73. PubMed ID: 19159929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolism in patients with monoclonal gammopathy of undetermined significance.
    Muslimani AA; Spiro TP; Chaudhry AA; Taylor HC; Jaiyesimi I; Daw HA
    Clin Adv Hematol Oncol; 2009 Dec; 7(12):827-32. PubMed ID: 20332755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
    Kyle RA; Therneau TM; Rajkumar SV; Offord JR; Larson DR; Plevak MF; Melton LJ
    N Engl J Med; 2002 Feb; 346(8):564-9. PubMed ID: 11856795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)].
    Adam Z; Nedbálková M; Krejcí M; Pour L; Husek K; Veselý K; Cermáková Z; Krivanová A; Mayer J; Hájek R
    Vnitr Lek; 2010 Mar; 56(3):240-6. PubMed ID: 20394211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.
    Baldini L; Goldaniga M; Guffanti A; Broglia C; Cortelazzo S; Rossi A; Morra E; Colombi M; Callea V; Pogliani E; Ilariucci F; Luminari S; Morel P; Merlini G; Gobbi P
    J Clin Oncol; 2005 Jul; 23(21):4662-8. PubMed ID: 16034042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance.
    Kumar S; Rajkumar SV; Kyle RA; Lacy MQ; Dispenzieri A; Fonseca R; Lust JA; Gertz MA; Greipp PR; Witzig TE
    J Clin Oncol; 2005 Aug; 23(24):5668-74. PubMed ID: 16110026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
    Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C
    Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal gammopathy of undeterminated significance: introduction and current clinical issues.
    Klincová M; Sandecká V; Mikuláiová A; Radocha J; Maisnar V; Hájek R
    Klin Onkol; 2011; 24 Suppl():S14-7. PubMed ID: 21923058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients.
    Amara S; Dezube BJ; Cooley TP; Pantanowitz L; Aboulafia DM
    Clin Infect Dis; 2006 Nov; 43(9):1198-205. PubMed ID: 17029142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
    Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
    Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal gammopathy of undetermined significance.
    Kyle RA
    Blood Rev; 1994 Sep; 8(3):135-41. PubMed ID: 7819815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.